Skip to main content
. 2019 May 30;52(1):109–116. doi: 10.4143/crt.2019.202

Table 1.

Demographic and clinical pathologic information between NPC survivors and sporadic oral SCC patients

NPC survivor (n=83) Sporadic oral SCC (n=1,158) p-value
Age (yr)
 ≥ 60 46 632 0.881
 < 60 37 526
Sex
 Male 67 891 0.428
 Female 16 267
Drinker
 Yes 8 200 0.072
 No 75 958
Smoker
 Yes 11 323 0.004
 No 72 835
Tumor site
 Tongue 54 486 0.004
 Mouth floor 6 312
 Buccal 13 203
 Lower gingiva 10 157
Tumor stage
 T1+T2 59 736 0.167
 T3+T4 24 422
Disease stage
 I+Ⅱ 51 633 0.230
 Ⅲ+Ⅳ 32 525
Node stage
 N0 55 789 0.724
 N+ 28 369
Differentiation
 Well 47 554 0.133
 Moderate 23 377
 Poor 13 167
 Unknown 0 60
Perineural invasion
 Positive 23 130 < 0.001
 Negative 60 949
 Unknown 0 79
Lymphovascular invasion
 Positive 16 153 < 0.001
 Negative 67 955
 Unknown 0 50
Treatment
 S 15 145 0.235
 S+R 30 369
 S+R+C 38 612

NPC, nasopharyngeal carcinoma; SCC, squamous cell carcinoma; S, surgery; R, radiotherapy; C, chemotherapy.